Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000929624-00-000292
Filing Date
2000-03-03
Accepted
2000-03-03 00:00:00
Documents
1
Group Members
ANSELM LEUNG ("LEUNG")BIOASIA INVESTMENTS LLCBIOASIA, LLC ("BA")BIOTECHNOLOGY DEVELOPMENT FUND III, L.P.BIOTECHNOLOGY DEVELOPMENT FUND, L.P.EDGAR ENGLEMAN ("ENGLEMAN")FRANK KUNG ("KUNG")

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D SC 13D/A 35064
  Complete submission text file 0000929624-00-000292.txt   37414
Mailing Address 2033 GATEWAY PLACE SUITE 600 SAN JOSE CA 95110
Business Address 2033 GATEWAY PLACE SUITE 600 SAN JOSE CA 95110 4089882500
CELTRIX PHARMACEUTICALS INC (Subject) CIK: 0000871395 (see all company filings)

EIN.: 943121462 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-41502 | Film No.: 560592
SIC: 2834 Pharmaceutical Preparations

Mailing Address 575 HIGH STREET STE 201 PALO ALTO CA 94301
Business Address 575 HIGH STREET SUITE 201 PALO ALTO CA 94301 6506880821
BIOASIA INVESTMENTS LLC (Filed by) CIK: 0001103307 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231